Theralia AB
PrivateLast Round
Early Funding
Jan 30, 2024
Company Overview
Theralia AB operates in Healthcare & Life Sciences and is based in Linköping. It was founded in 2021.
Theralia AB is a biotechnology company that develops oligonucleotide-based drug delivery technology for the targeted administration of antimicrobial therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theralia AB Comparables
Compare Theralia AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Paralos Bioscience | 81% | |
| Sixfold Bioscience | 78% | |
| Procarta Biosystems | 76% |
For institutional investors. Book with your work email.
Theralia AB Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Theralia AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INCATE | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2024
Company raised an early funding round.
For institutional investors. Book with your work email.
Theralia AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Theralia AB's valuation, stock price, and market status.
Is Theralia AB a public or private company?
Theralia AB is a private company.
What is the current stock price of Theralia AB?
Theralia AB is a private company, so its shares have no public market price. Caplight tracks Theralia AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Theralia AB worth (valuation)?
Valuation information for Theralia AB is not publicly available.
Can I buy Theralia AB stock?
Theralia AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Theralia AB's last funding round?
Theralia AB's most recent funding round was Early Funding on January 30, 2024.
Who are the main investors in Theralia AB?
Key investors in Theralia AB include INCATE.
Will Theralia AB IPO soon?
No public IPO plans have been announced for Theralia AB.
How can I track Theralia AB secondary market activity?
Caplight tracks bids, offers, and trades in Theralia AB's shares on secondary markets.